The following indications represent Beech Tree's product candidates that have issued patents and have also been the subject of animal model and/or pre-clinical evaluation. Detailed plans for their further development and evaluation have been established and are subject to financing. Other formulations, such as those for dementia, narcolepsy, and myasthenia gravis, are not yet protected by patent and are in various phases of initial development.